Bird & Bird advised Biomemory on its €17 million fundraising round

Published

Dec 23 2024

Related

Practices

Sectors

Countries

International law firm Bird & Bird advised Biomemory, a French deeptech pioneer in DNA data storage, on its €17 million Series A funding round, with new investors Crédit Mutuel Innovation, Blast.club, Bpifrance, Sorbonne Venture and Adnexus, and its existing shareholders.

Founded in 2021, this innovative deeptech spin-off from CNRS/Sorbonne University’s first objective is to produce DNA printers that can transform binary information into AGTC information (the four types of DNA nucleotide).

Two years after a €5 million seed round, Biomemory plans to use this new funding to expand its team by recruiting promising talent in molecular biology and engineering to accelerate product development and commercialisation. 

The Bird & Bird team advising on the deal consisted of lead partner Félicien Bardsley and associate Céline Sol. 

News & Deals

More News & Deals
Deal Bird & Bird advises Ciclad on acquiring a majority stake in Capelec Group

Oct 22 2025

Read More
News Bird & Bird Sponsors Slush for Fourth Consecutive Year

Oct 20 2025

Read More
Deal Bird & Bird advises FUJIFILM Healthcare on acquisition of endoscopy business

Oct 16 2025

Read More
Deal Bird & Bird advises Integrated Eduverse on Sale of SUN Education to StudyIn

Oct 16 2025

Read More
Deal Bird & Bird advises Obton A/S on financing the development costs of 72 photovoltaic farms in Poland

Oct 14 2025

Read More
Deal Bird & Bird advises Serwent on strategic acquisition of Röranalys i Sverige AB and ISAB Rörinfodring AB

Oct 10 2025

Read More
More News & Deals

Related capabilities

Corporate Venture Capital Technology & Communications Life Sciences and Healthcare